PFS and OS by consolidation strategy stratified by RPA class among patients who achieved CR/CRu to consolidation. In patients who received cytarabine alone, median OS was 7.7 years for RPA class 2 and 4.4 years for RPA class 3. In patients who received RD-WBRT, median OS was 13.0 years for RPA class 2 and 10.0 years for RPA class 3. In patients who received AHCT median OS was 9.4 years for RPA class 2 and 1.1 years for RPA class 3.